EDGAR Filing Documents for 0001144204-05-033237

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-05-033237

Filing Date

2005-10-31

Accepted

2005-10-28 19:48:41

Documents

Period of Report

2005-07-31

Document Format Files

Seq	Description	Document	Type	Size
1		v027763.htm	10-K	4963174
2		v027763_ex425-2.htm	EX-4.25.2	192171
3		v027763_ex425-3.htm	EX-4.25.3	117984
4		v027763_ex425-4.htm	EX-4.25.4	102415
5		v027763_ex427-1.htm	EX-4.27.1	16155
6		v027763_ex427-2.htm	EX-4.27.2	103234
7		v027763_ex428-1.htm	EX-4.28.1	15568
8		v027763_ex428-2.htm	EX-4.28.2	101172
9		v027763_ex4-29.htm	EX-4.29	118020
10		v027763_ex4-30.htm	EX-4.30	118537
11		v027763_ex4-31.htm	EX-4.31	117499
12		v027763_ex21.htm	EX-21	8575
13		v027763_ex23-1.htm	EX-23.1	3967
14		v027763_ex31-1.htm	EX-31.1	22878
15		v027763_ex31-2.htm	EX-31.2	23103
16		v027763_ex32.htm	EX-32	10572
	Complete submission text file	0001144204-05-033237.txt		6036469

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)